Cannabinoid Hyperemesis Syndrome

Background The purpose of this review is to describe cannabinoid hyperemesis syndrome (CHS), which is thought to be induced by long-term cannabis use, and provide clinical pharmacists with information to manage the hyperemetic phase of CHS. Method Published literature was searched and reviewed using...

Full description

Saved in:
Bibliographic Details
Published in:Hospital pharmacy (Philadelphia) 2013-09, Vol.48 (8), p.650-655
Main Authors: Sun, Shusen, Zimmermann, Anthony E.
Format: Article
Language:English
Subjects:
Original
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3290-6fddb1d161847d028706a9b3532f148864de0976f9ff892cb045082b581f00d3
cites cdi_FETCH-LOGICAL-c3290-6fddb1d161847d028706a9b3532f148864de0976f9ff892cb045082b581f00d3
container_end_page 655
container_issue 8
container_start_page 650
container_title Hospital pharmacy (Philadelphia)
container_volume 48
creator Sun, Shusen
Zimmermann, Anthony E.
description Background The purpose of this review is to describe cannabinoid hyperemesis syndrome (CHS), which is thought to be induced by long-term cannabis use, and provide clinical pharmacists with information to manage the hyperemetic phase of CHS. Method Published literature was searched and reviewed using PubMed. Results CHS is characterized by intractable nausea and vomiting without an obvious organic cause and associated learned compulsive hot water bathing behavior. Patients often seek care in the emergency department (ED) for symptomatic relief. Conclusion CHS is potentially underrecognized and underdiagnosed in the ED, and it should be considered in the differential diagnosis in long-term cannabis use patients with CHS symptoms to avoid unnecessary extensive diagnostic workup including invasive radiologic imaging. Pharmacists have an important role in CHS recognition, education, and symptom management.
doi_str_mv 10.1310/hpj4808-650
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3847982</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1310_hpj4808-650</sage_id><sourcerecordid>1490697778</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3290-6fddb1d161847d028706a9b3532f148864de0976f9ff892cb045082b581f00d3</originalsourceid><addsrcrecordid>eNptkE1LAzEQhoMotlZP3qVHQVYnX5vkIkhRKxQ82HvIbpJ2y-6mJl2h_96V1qrgaRjm4X2HB6FLDLeYYrhbrldMgsxyDkdoiBXjGSacHqMhAJYZF1IM0FlKq34VlNBTNCCMEcwpH6LxxLStKao2VHY83a5ddI1LVRq_bVsbQ-PO0Yk3dXIX-zlC86fH-WSazV6fXyYPs6ykREGWe2sLbHGOJRMWiBSQG1VQTonHTMqcWQdK5F55LxUpC2AcJCm4xB7A0hG638Wuu6JxtnTtJppar2PVmLjVwVT676WtlnoRPjTt-5QkfcD1PiCG986ljW6qVLq6Nq0LXdKYKciVEEL26M0OLWNIKTp_qMGgv5TqvVLdK-3pq9-fHdhvhz_NySycXoUutr2of7M-Ab-kfVQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1490697778</pqid></control><display><type>article</type><title>Cannabinoid Hyperemesis Syndrome</title><source>SAGE:Jisc Collections:SAGE Journals Read and Publish 2023-2024:2025 extension (reading list)</source><source>PubMed Central</source><creator>Sun, Shusen ; Zimmermann, Anthony E.</creator><creatorcontrib>Sun, Shusen ; Zimmermann, Anthony E.</creatorcontrib><description>Background The purpose of this review is to describe cannabinoid hyperemesis syndrome (CHS), which is thought to be induced by long-term cannabis use, and provide clinical pharmacists with information to manage the hyperemetic phase of CHS. Method Published literature was searched and reviewed using PubMed. Results CHS is characterized by intractable nausea and vomiting without an obvious organic cause and associated learned compulsive hot water bathing behavior. Patients often seek care in the emergency department (ED) for symptomatic relief. Conclusion CHS is potentially underrecognized and underdiagnosed in the ED, and it should be considered in the differential diagnosis in long-term cannabis use patients with CHS symptoms to avoid unnecessary extensive diagnostic workup including invasive radiologic imaging. Pharmacists have an important role in CHS recognition, education, and symptom management.</description><identifier>ISSN: 0018-5787</identifier><identifier>EISSN: 1945-1253</identifier><identifier>DOI: 10.1310/hpj4808-650</identifier><identifier>PMID: 24421535</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Original</subject><ispartof>Hospital pharmacy (Philadelphia), 2013-09, Vol.48 (8), p.650-655</ispartof><rights>2013 SAGE Publications</rights><rights>2013 Thomas Land Publishers, Inc. 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3290-6fddb1d161847d028706a9b3532f148864de0976f9ff892cb045082b581f00d3</citedby><cites>FETCH-LOGICAL-c3290-6fddb1d161847d028706a9b3532f148864de0976f9ff892cb045082b581f00d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847982/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847982/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24421535$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sun, Shusen</creatorcontrib><creatorcontrib>Zimmermann, Anthony E.</creatorcontrib><title>Cannabinoid Hyperemesis Syndrome</title><title>Hospital pharmacy (Philadelphia)</title><addtitle>Hosp Pharm</addtitle><description>Background The purpose of this review is to describe cannabinoid hyperemesis syndrome (CHS), which is thought to be induced by long-term cannabis use, and provide clinical pharmacists with information to manage the hyperemetic phase of CHS. Method Published literature was searched and reviewed using PubMed. Results CHS is characterized by intractable nausea and vomiting without an obvious organic cause and associated learned compulsive hot water bathing behavior. Patients often seek care in the emergency department (ED) for symptomatic relief. Conclusion CHS is potentially underrecognized and underdiagnosed in the ED, and it should be considered in the differential diagnosis in long-term cannabis use patients with CHS symptoms to avoid unnecessary extensive diagnostic workup including invasive radiologic imaging. Pharmacists have an important role in CHS recognition, education, and symptom management.</description><subject>Original</subject><issn>0018-5787</issn><issn>1945-1253</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNptkE1LAzEQhoMotlZP3qVHQVYnX5vkIkhRKxQ82HvIbpJ2y-6mJl2h_96V1qrgaRjm4X2HB6FLDLeYYrhbrldMgsxyDkdoiBXjGSacHqMhAJYZF1IM0FlKq34VlNBTNCCMEcwpH6LxxLStKao2VHY83a5ddI1LVRq_bVsbQ-PO0Yk3dXIX-zlC86fH-WSazV6fXyYPs6ykREGWe2sLbHGOJRMWiBSQG1VQTonHTMqcWQdK5F55LxUpC2AcJCm4xB7A0hG638Wuu6JxtnTtJppar2PVmLjVwVT676WtlnoRPjTt-5QkfcD1PiCG986ljW6qVLq6Nq0LXdKYKciVEEL26M0OLWNIKTp_qMGgv5TqvVLdK-3pq9-fHdhvhz_NySycXoUutr2of7M-Ab-kfVQ</recordid><startdate>20130901</startdate><enddate>20130901</enddate><creator>Sun, Shusen</creator><creator>Zimmermann, Anthony E.</creator><general>SAGE Publications</general><general>Thomas Land Publishers, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20130901</creationdate><title>Cannabinoid Hyperemesis Syndrome</title><author>Sun, Shusen ; Zimmermann, Anthony E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3290-6fddb1d161847d028706a9b3532f148864de0976f9ff892cb045082b581f00d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Original</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sun, Shusen</creatorcontrib><creatorcontrib>Zimmermann, Anthony E.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Hospital pharmacy (Philadelphia)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sun, Shusen</au><au>Zimmermann, Anthony E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cannabinoid Hyperemesis Syndrome</atitle><jtitle>Hospital pharmacy (Philadelphia)</jtitle><addtitle>Hosp Pharm</addtitle><date>2013-09-01</date><risdate>2013</risdate><volume>48</volume><issue>8</issue><spage>650</spage><epage>655</epage><pages>650-655</pages><issn>0018-5787</issn><eissn>1945-1253</eissn><abstract>Background The purpose of this review is to describe cannabinoid hyperemesis syndrome (CHS), which is thought to be induced by long-term cannabis use, and provide clinical pharmacists with information to manage the hyperemetic phase of CHS. Method Published literature was searched and reviewed using PubMed. Results CHS is characterized by intractable nausea and vomiting without an obvious organic cause and associated learned compulsive hot water bathing behavior. Patients often seek care in the emergency department (ED) for symptomatic relief. Conclusion CHS is potentially underrecognized and underdiagnosed in the ED, and it should be considered in the differential diagnosis in long-term cannabis use patients with CHS symptoms to avoid unnecessary extensive diagnostic workup including invasive radiologic imaging. Pharmacists have an important role in CHS recognition, education, and symptom management.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>24421535</pmid><doi>10.1310/hpj4808-650</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0018-5787
ispartof Hospital pharmacy (Philadelphia), 2013-09, Vol.48 (8), p.650-655
issn 0018-5787
1945-1253
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3847982
source SAGE:Jisc Collections:SAGE Journals Read and Publish 2023-2024:2025 extension (reading list); PubMed Central
subjects Original
title Cannabinoid Hyperemesis Syndrome
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T07%3A51%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cannabinoid%20Hyperemesis%20Syndrome&rft.jtitle=Hospital%20pharmacy%20(Philadelphia)&rft.au=Sun,%20Shusen&rft.date=2013-09-01&rft.volume=48&rft.issue=8&rft.spage=650&rft.epage=655&rft.pages=650-655&rft.issn=0018-5787&rft.eissn=1945-1253&rft_id=info:doi/10.1310/hpj4808-650&rft_dat=%3Cproquest_pubme%3E1490697778%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3290-6fddb1d161847d028706a9b3532f148864de0976f9ff892cb045082b581f00d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1490697778&rft_id=info:pmid/24421535&rft_sage_id=10.1310_hpj4808-650&rfr_iscdi=true